---
document_datetime: 2023-09-21 20:21:46
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/prepandrix-epar-all-authorised-presentations_en.pdf
document_name: prepandrix-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7979338
conversion_datetime: 2025-12-18 20:41:52.235897
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number                                 | Invented                                  | Strength                                  | Pharmaceutical                                          | Route of                                  | Packaging                                                                    | Content                                   | Package size                                  |
|-------------------------------------------|-------------------------------------------|-------------------------------------------|---------------------------------------------------------|-------------------------------------------|------------------------------------------------------------------------------|-------------------------------------------|-----------------------------------------------|
| EU/1/08/453/002 Split influenza virus     | name Prepandrix containing antigen        | 3.75 µg HA 1 * equivalent                 | Form Suspension and Emulsion for emulsion for injection | Administration Intramuscular use longer   | suspension (H5N1): vial (glass) emulsion (adjuvant): vial (glass) authorised | 2.5 ml (suspension) 2.5 ml (emulsion)     | 50 vials (suspension) 2 x 25 vials (emulsion) |
| 1 After mixing, 1 dose (0.5 ml) contains: | 1 After mixing, 1 dose (0.5 ml) contains: | 1 After mixing, 1 dose (0.5 ml) contains: | 1 After mixing, 1 dose (0.5 ml) contains:               | 1 After mixing, 1 dose (0.5 ml) contains: | 1 After mixing, 1 dose (0.5 ml) contains:                                    | 1 After mixing, 1 dose (0.5 ml) contains: | 1 After mixing, 1 dose (0.5 ml) contains:     |

AS03 adjuvant composed of squalene (10.69 milligrams), DLα -tocopherol (11.86 milligrams) and polysorbate 80 (4.86 milligrams)

Medicinal Product no longer authorised